Skip to main content
TipRanks
Go Ultimate75% OFF

Denali Therapeutics (DNLI) Revenue

892 Followers

Denali Therapeutics Revenue

Revenue (ttm)
21.38M
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
503
Market Cap
$3.18B

Revenue Chart

Denali Therapeutics Revenue - Annual

0100M200M300M400M129.16M26.68M335.66M48.66M108.46M330.53M201720182019202020212022202320242025
Revenue History
Download to Excel
DNLI revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20250.000.00―
Dec 31, 20240.00-330.53M-100.00%
Dec 31, 2023330.53M222.07M204.74%
Dec 31, 2022108.46M59.80M122.90%
Dec 31, 202148.66M-287.00M-85.50%
Dec 31, 2020335.66M308.98M1158.19%
Dec 31, 201926.68M-102.48M-79.34%
Dec 31, 2018129.16M129.16M―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DNLI21.38M
QURE20.17M
XENE0.00
WVE70.92M
STOK28.21M
TSHA5.49M